Armistice Capital LLC grew its stake in shares of NLS Pharmaceutics Ltd. (NASDAQ:NLSP – Free Report) by 6.4% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,311,000 shares of the company’s stock after acquiring an additional 139,000 shares during the period. Armistice Capital LLC owned 19.62% of NLS Pharmaceutics worth $501,000 as of its most recent SEC filing.
NLS Pharmaceutics Trading Down 5.5 %
Shares of NASDAQ:NLSP opened at $0.13 on Friday. NLS Pharmaceutics Ltd. has a 1 year low of $0.11 and a 1 year high of $1.02. The business has a fifty day simple moving average of $0.17 and a 200 day simple moving average of $0.17.
About NLS Pharmaceutics
See Also
- Five stocks we like better than NLS Pharmaceutics
- Are Penny Stocks a Good Fit for Your Portfolio?
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for NLS Pharmaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NLS Pharmaceutics and related companies with MarketBeat.com's FREE daily email newsletter.